RBC Bioscience Corporation Share Price
Equities
6848
TW0006848005
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.05 TWD | +0.31% | +0.94% | -0.93% |
Sales 2022 | 17Cr 53.57L 45Cr | Sales 2023 | 17Cr 53.13L 44Cr | Capitalization | 21Cr 64.76L 54Cr |
---|---|---|---|---|---|
Net income 2022 | 30L 92.42T 77.09L | Net income 2023 | 60L 2L 1.54Cr | EV / Sales 2022 | 3.52 x |
Net Debt 2022 | 41Cr 1.25Cr 104.28Cr | Net Debt 2023 | 41Cr 1.25Cr 104.45Cr | EV / Sales 2023 | 3.58 x |
P/E ratio 2022 |
54.7
x | P/E ratio 2023 |
33.1
x | Employees | - |
Yield 2022 |
7.07% | Yield 2023 |
2.72% | Free-Float | 71.49% |
1 day | +0.31% | ||
1 week | +0.94% | ||
1 month | +0.63% | ||
Current year | -0.93% |
Managers | Title | Age | Since |
---|---|---|---|
Ming Wei Zhuo
CEO | Chief Executive Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Tsun Yuan Cho
BRD | Director/Board Member | - | - |
Ming Wei Zhuo
CEO | Chief Executive Officer | - | - |
Jun Yong Zhuo
BRD | Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
31/24/31 | 16.05 | +0.31% | 30,005 |
30/24/30 | 16 | +0.63% | 37,780 |
29/24/29 | 15.9 | -0.93% | 32,102 |
28/24/28 | 16.05 | -0.31% | 2,001 |
27/24/27 | 16.1 | +1.26% | 25,005 |
End-of-day quote Taipei Exchange, May 31, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-0.93% | 64.03L | |
-7.16% | 18TCr | |
-4.86% | 6.7TCr | |
-4.28% | 4.72TCr | |
+10.32% | 4.46TCr | |
+8.14% | 4.25TCr | |
+15.76% | 3TCr | |
+15.53% | 2.52TCr | |
-5.88% | 2.41TCr | |
-5.38% | 2.37TCr |
- Stock Market
- Equities
- 6848 Stock